Deborah Palacios Reyes

Dr. Deborah Palacios Reyes

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
JMJocelin Merida-Vieyra
Jocelin Merida-Vieyra
AAAlejandra Aquino-Andrade
Alejandra Aquino-Andrade
DRDeborah Palacios Reyes
Deborah Palacios Reyes
CMChiharu Murata
Chiharu Murata
RRRosa María Ribas-Aparicio
Rosa María Ribas-Aparicio
ARAgustin De Colsa Ranero
Agustin De Colsa Ranero
Purpose: Mycoplasma pneumoniae is an important cause of community-acquired pneumonia (CAP). Information on the prevalence of M. pneumoniae in pediatric patients with CAP in Mexico is limited. The aim of this study was to detect M. pneumoniae in hospitalized pediatric patients with CAP. Patients and methods: We performed a descriptive study in a tertiary-level pediatric reference center, obtaining 154 respiratory samples from patients under 18 years of age and diagnosed with CAP. M. pneumoniae was detected by real-time polymerase chain reaction (PCR) targeting the p1 and CARDS genes. Complete blood cell count, measurement of C-reactive protein and detection of IgM and IgG anti-P1 were performed. Clinical, epidemiological and radiological data of the patients were analyzed. Results: M. pneumoniae was detected by real-time PCR in 26.6% of the samples. 39% of the cases occurred during the spring season. A total of 83% of the patients with M. pneumoniae had some underlying disease; renal disease, autoimmune disease and primary immunodeficiencies had a significant association with M. pneumoniae CAP. Children under 6 years of age represented 53.7% of the cases. Fever and cough were the most frequent symptoms. IgM and IgG were positive in 1.9% and 14% of the patients, respectively. In the chest X-ray, 17.1% of the patients showed multifocal alveolar infiltrates pattern. The complications in this series were 26.8%. The mortality in this study was 4.9%. Conclusion: This is the first report in Mexico about M. pneumoniae as a causal agent of CAP in a tertiary care pediatric hospital using real-time PCR and serology. M. pneumoniae was responsible for 26.6% of the cases and was frequent in children under 6 years of age. In addition, we described the clinical presentation in patients with underlying diseases.

29 June 2020 in Current Fungal Infection Reports
Verified
Journal Article
Open access
PDF file
DRDeborah Palacios Reyes
Deborah Palacios Reyes
ABAlexandro Bonifaz
Alexandro Bonifaz
Purpose of Review This review highlights the important features of conidiobolomycosis infection and describes its presentation in pediatric population. The importance of a broaden differential diagnosis to include fungal infections taking into account the geographical location and history of exposure. Recent Findings There is evidence of conidiobolomycosis affecting not only immunocompetent hosts but also more susceptible individuals that can present with atypical or systemic/disseminated disease, including children. Summary Conidiobolomycosis is a rare fungal infection caused by species of the genera Conidiobolus. It affects skin and soft tissue mainly from nasal and face location, though atypical presentation which consists of orbital/eye/maxillary sinus involvement and disseminated/systemic disease can be present. These forms of disease are more frequent in children and immunocompromised/chronic patients. Diagnosis should be established with culture and histopathology. Treatment is not standardized, but combination of antifungal drugs with surgical interventions has shown highest efficacy.

30 January 2022 in Current Fungal Infection Reports
Verified
Journal Article
Closed access
PDF file
DRDeborah Palacios Reyes
Deborah Palacios Reyes
MMMaría de los Ángeles Costta Michuy
María de los Ángeles Costta Michuy
TVTania M. Vargas-Vázquez
Tania M. Vargas-Vázquez
MMM. Vanessa Martínez-Astudillo
M. Vanessa Martínez-Astudillo
RVRafael Oscar Santamaría Vásquez
Rafael Oscar Santamaría Vásquez
SFSilvia Fuentes-Soliz
Silvia Fuentes-Soliz

7 March 2022 in Medical Mycology Case Reports
Verified
Journal Article
Open access
JOJavier Ordoñez-Ortega
Javier Ordoñez-Ortega
ABAna María Borbolla-Pertierra
Ana María Borbolla-Pertierra
YSYolotl Sánchez-Carrillo
Yolotl Sánchez-Carrillo
MMMaría de los Ángeles Costta Michuy
María de los Ángeles Costta Michuy
MMMónica Mirabal-García
Mónica Mirabal-García
DRDeborah Palacios Reyes
Deborah Palacios Reyes
Here we present two cases of entomophthoramycosis in young children, these were the first cases ever diagnosed at our center. Both cases represented a diagnostic and treatment challenge. Surgical treatment was key in the management of both patients. Even though atypical disease was encountered, clinical response was obtained after surgical excision and antifungal treatment for a few months.

18 July 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
TCTiareth Cova-Guzmán
Tiareth Cova-Guzmán
DRDeborah Palacios Reyes
Deborah Palacios Reyes
CRCarla M. Roman-Montes
Carla M. Roman-Montes
MYMarco Yamazaki-Nakashimada
Marco Yamazaki-Nakashimada
ABAidé Tamara Staines Boone
Aidé Tamara Staines Boone
LGLizbeth Blancas Galicia
Lizbeth Blancas Galicia
In chronic granulomatous disease (CGD), Aspergillus is the most common cause of invasive fungal infections and accounts for a high percentage of mortality. We recruited 45 patients of CGD with invasive aspergillosis (IA) events. The median age between the first CGD manifestation and first aspergillosis event was 65 mo. Mortality rate was 57.7% for proven aspergillosis events, 23.1% for probable events, and 19.2% for possible events (p = 0.038). Aspergillus fumigatus was the most common species. Comparing mortality with this cutoff point, 36% of those receiving 75 days (p = 0.05). 26 (58%) of the 45 patients died, out of which 18 (69%) had IA. Overall survival of the 45 patients was 80.8% at 64 mo. The high mortality rate of IA in CGD patients could be reduced by early suspicion, initiating correct antifungal treatment over a long period, and considering the performance of hematopoietic stem cell transplantation.

8 September 2026 in Frontiers in Tropical Diseases
Verified
Journal Article
Open access
PDF file
DRDeborah Palacios Reyes
Deborah Palacios Reyes
SCSergio Abraham Cantú-Martinez
Sergio Abraham Cantú-Martinez
AGAna Karen Gómez Gutiérrez
Ana Karen Gómez Gutiérrez
JCJuan Rigoberto Calderón-Escamilla
Juan Rigoberto Calderón-Escamilla
SMScott Alonso Macías-Rodríguez
Scott Alonso Macías-Rodríguez
ACAgustín De Colsa
Agustín De Colsa
Introduction: Histoplasmosis is a systemic mycosis caused by the dimorphic fungus Histoplasma capsulatum (H.capsulatum) . It represents a diagnostic challenge in the pediatric population due to its non-specific clinical presentation, frequently mimicking tuberculosis or malignancies. This study aims to describe the clinical, radiological, and laboratory characteristics of a case series of pediatric patients to optimize early recognition and timely management. Materials and methods: a retrospective and descriptive review of all proven histoplasmosis cases (EORTC/MSGERC criteria) diagnosed and managed at Instituto Nacional de Pediatría, a tertiary-care national referral pediatric center in Mexico over a 5-year period (2020–2025). Demographic, clinical, mycological, and therapeutic variables were analyzed. Results: The median age was 12 years (range: 1–15 years), with male predominance (71.4%). Underlying immunosuppression or comorbidities (HIV/AIDS, hematological malignancies and renal transplantation) were present in 57.1% of cases. Relevant epidemiological exposure was identified in 71.4% of patients. Persistent fever was the most frequent symptom (85.7%). Extrapulmonary involvement was documented in three patients (42.8%), including mesenteric lymph node, bone marrow, and epidural involvement. One patient developed hemophagocytic lymphohistiocytosis. Diagnosis was established by histopathology (85.7%). Liposomal amphotericin B followed by itraconazole was the primary therapeutic regimen. Overall mortality was 14.2%. Discussion: Histoplasmosis remains underdiagnosed in children due to its heterogeneous presentation. Maintaining a high index of suspicion and evaluating epidemiological risk factors are essential, especially in immunocompromised hosts, to prevent diagnostic delays and severe complications such as hemophagocytic lymphohistiocytosis or central nervous system involvement.